NCT00171847View on ClinicalTrials.gov

Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer

PHASE4TerminatedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

October 31, 2008

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Letrozole

DRUG

Trastuzumab plus Letrozole

DRUG

Letrozole

Trial Locations (1)

Unknown

Novartis Investigative Site, Tübingen

Sponsors
All Listed Sponsors
collaborator

Roche - Prof. Dr. Jens Huober et al.

UNKNOWN

lead

Novartis Pharmaceuticals

INDUSTRY